Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × CF regimen × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Squamous Cell Carcinoma 1

Interventions

pembrolizumab 1054 Specimen Handling 696 Carboplatin 694 Cyclophosphamide 672 Magnetic Resonance Spectroscopy 651 Cisplatin 594 Nivolumab 569 Paclitaxel 523 Radiotherapy 467 Gemcitabine 462 Biopsy 425 Bevacizumab 383 Dexamethasone 374 fludarabine 339 Docetaxel 329 venetoclax 325 Oxaliplatin 303 atezolizumab 303 Capecitabine 299 Fluorouracil 299 Rituximab 289 durvalumab 279 Radiosurgery 261 Pemetrexed 259 Doxorubicin 255 Drug Therapy 254 Ipilimumab 253 Standard of Care 247 Lenalidomide 239 Radiation 239

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04550260 2026-01-29

KUNLUN

AstraZeneca

Phase 3 Active not recruiting

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡